TMEM126A and breast cancer: Moreover, both in vitro and in vivo invasive breast cancer cells show a loss of transmembrane protein 126A (TMEM126A), mitochondrial retrograde signaling alterations, EMT induction, and altered extracellular matrix composition [48].